HX9428

· Fujian Haixi Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HX9428, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD) [Phase 1, Phase 2]

See pricing